Cantor Fitzgerald Issues Positive Forecast for BMRN Earnings
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Equities research analysts at Cantor Fitzgerald raised their FY2025 earnings per share estimates for shares of BioMarin Pharmaceutical in a research report issued on Thursday, February 20th. Cantor Fitzgerald analyst O. Brayer now anticipates that the biotechnology company will earn $3.53 per share for the year, up […]
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Equities research analysts at Cantor Fitzgerald raised their FY2025 earnings per share estimates for shares of BioMarin Pharmaceutical in a research report issued on Thursday, February 20th. Cantor Fitzgerald analyst O. Brayer now anticipates that the biotechnology company will earn $3.53 per share for the year, up […]
